Ensysce Biosciences, Inc. (ENSC)

Ensysce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.31	3.5	1.12	3.15	12.26
Cash & Short-Term Investments	4.31	3.5	1.12	3.15	12.26
Cash Growth	23.08%	211.68%	-64.30%	-74.33%	6215.04%
Accounts Receivable	0.42	0.12	0.1	0.28	0.44
Other Current Assets	2.51	1.72	1.07	1.85	2.93
Total Current Assets	7.24	5.34	2.29	5.3	15.66
Net Property, Plant & Equipment	0.12	-	-	0.03	0.78
Other Long-Term Assets	0.09	0.25	0.42	0.59	-
Total Assets	7.45	5.6	2.71	5.89	16.42
Accounts Payable	3.27	1.36	1.94	2.94	0.3
Accrued Expenses	0.99	0.55	0.54	2.23	3.41
Short-Term Debt	0.31	0.3	0.85	4.27	12.75
Current Portion of Leases	-	-	-	0.03	0.02
Total Current Liabilities	4.57	2.21	3.33	9.46	16.48
Long-Term Debt	-	-	-	0.14	4.44
Other Long-Term Liabilities	-	0.01	0.03	0.31	3.65
Total Long-Term Liabilities	-	0.01	0.03	0.45	8.09
Total Liabilities	4.57	2.22	3.36	9.91	24.58
Common Stock	0	0	0	0	0
Additional Paid-in Capital	142.93	133.25	121.23	107.22	77.97
Retained Earnings	-139.72	-129.54	-121.56	-110.93	-85.85
Total Common Shareholders' Equity	3.21	3.71	-0.32	-3.71	-7.88
Minority Interest	-0.33	-0.33	-0.33	-0.32	-0.28
Shareholders' Equity	2.88	3.38	-0.65	-4.03	-8.16
Total Liabilities & Equity	7.45	5.6	2.71	5.89	16.42
Total Debt	0.31	0.3	0.85	4.43	17.21
Net Cash (Debt)	4	3.2	0.27	-1.29	-4.95
Net Cash Growth	25.10%	1090.16%	-	-	-
Net Cash Per Share	1.57	4.59	1.78	-107.24	-883.60
Book Value	3.21	3.71	-0.32	-3.71	-7.88
Book Value Per Share	1.26	5.32	-2.14	-309.67	-1406.53
Tangible Book Value	3.21	3.71	-0.32	-3.71	-7.88
Tangible Book Value Per Share	1.26	5.32	-2.14	-309.67	-1406.53

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q